LENZ Therapeutics Growth Metrics (2022-2025) | LENZ

Growth Metrics Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Growth Ratios
EBITDA Margin (QoQ) (Quarter) 16,785.00-212742.00
EBIT Margin (QoQ) (Quarter) 18,604.00-227101.00
EBT Margin (QoQ) (Quarter) 15,464.00-212673.00
Enterprise Value Growth (1y) (Quarter) 40.37%23.47%19.78%0.88%20.49%82.42%88.45%80.77%38.27%-39.86%
Enterprise Value Growth (3y) (Quarter) 59.13%51.08%55.68%-2.91%
Enterprise Value (QoQ) (Quarter) 4.98%9.50%8.04%24.60%-21.96%5.14%2.17%79.02%-408.02%88.92%-62.90%32.67%-1,051.02%
FCF Margin (QoQ) (Quarter) 16,274.00-200984.00
Net Margin (QoQ) (Quarter) 16,464.00-212685.00
Operating Margin (QoQ) (Quarter) 18,604.00-227101.00
Return on Assets Growth (1y) (Quarter) 4.00-1.001.002.003.00-2.00-10.00
Return on Assets Growth (3y) (Quarter) 0.00
Return on Assets (QoQ) (Quarter) 3.002.001.00-3.003.004.00-1.00-2.00-2.00-4.00
Return on Capital Employed Growth (1y) (Quarter) 2.00-4.00-3.00-1.001.00-4.00-10.00
Return on Capital Employed Growth (3y) (Quarter) -5.00
Return on Capital Employed (QoQ) (Quarter) 3.002.000.00-4.002.003.00-2.00-1.00-3.00-4.00
Return on Equity Growth (1y) (Quarter) -399.00-213.00-147.0071.004.00-3.00-11.00
Return on Equity Growth (3y) (Quarter) 38.00
Return on Equity (QoQ) (Quarter) 376.00-121.00-62.0065.003.004.00-1.00-2.00-3.00-5.00
Return on Invested Capital (QoQ) (Quarter) -3.00-4.00
Return on Sales (QoQ) (Quarter) 165.00-2127.00